Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07737171) titled 'Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions' on July 27.
Study Type: Observational [Patient Registry]
Primary Sponsor: The University of Texas Health Science Center, Houston
Condition:
Pancreatic Cancer
Intervention:
Device: Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA)
Recruitment Status: Recruiting
Date of First Enrollment: April 7, 2026
Target Sample Size: 60
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07737171
Disclaimer: Curated by HT Syndication....